A ngiogenesis, the formation of new blood vessels from preexisting vasculature, occurs during several pathological conditions such as rheumatoid arthritis and cancer.
A ngiogenesis, the formation of new blood vessels from preexisting vasculature, occurs during several pathological conditions such as rheumatoid arthritis and cancer. 1 Sprouting angiogenesis, a major mechanism of neovascularization, depends on a set of spatially and temporally strictly regulated processes, including (1) induction and selection of a leading tip cell among endothelial cells (ECs); (2) tip cell migration followed by stalk formation; (3) lumen formation and vessel anastomosis, and finally (4) stabilization of the immature vessel through the recruitment of mural cells (pericytes). 2 Key factors identified to regulate sprouting angiogenesis include vascular endothelial growth factor A (VEGFA), fibroblast growth factor 2 (FGF2), and platelet-derived growth factor B (PDGFB). Importantly, proteoglycans carrying heparan sulfate (HS) polysaccharide chains have been shown to bind these and other angiogenic modulators through their HS chains and act as coreceptors. HSPGs thereby support VEGFAand FGF2-signaling required for angiogenesis, as well as the formation of PDGFB gradients to allow for recruitment of pericytes along nascent vessels. [3] [4] [5] [6] [7] [8] [9] [10] HS biosynthesis is strictly regulated resulting in the formation of a multitude of sulfated protein-binding epitopes. The HS chains evolve by the stepwise addition of alternating glucuronic acid and N-acetylglucosamine residues by the HS polymerases exostosin 1 and 2 (EXT1 and EXT2) to oligosaccharide acceptor linkage regions attached to core proteins. As the HS chains grow in length, they undergo several consecutive modification steps, including N-deacetylation and N-sulfation of alternating N-acetylglucosamine residues by N-deacetylase/ N-sulfotransferases (NDSTs), epimerization of alternating glucuronic acid to iduronic acid by a C5-epimerase, and finally sulfation at various locations by O-sulfotransferases. It is important to note that although protein-protein interactions rely on unique primary sequences, HS-protein interactions depend on HS charge distribution as well as overall conformation, 11 rather than on a specific sequence of sulfated disaccharide units. 12 From this notion it follows that other sulfated polysaccharides such as chondroitin sulfate (CS), having a charge density similar to HS and also being attached to proteoglycan core proteins, may regulate growth factor activities in a fashion analogous to HS.
Several recent studies have shed light on the role of HS in vascular development. Mice that lack the HS-retention motif of PDGFB, or produce reduced levels of functional HS (due to deletion of Ndst1), display delayed pericyte recruitment, as well as defective attachment of pericytes to ECs. 10, 13 Endothelial-specific loss of Ndst1 has also been shown to inhibit tumor angiogenesis.
14 Further, a recent study examining pericyte-specific loss of Ext1 suggests that HSPGs must be expressed by the pericyte itself to allow for proper PDGF-and TGF-signaling during pericyte recruitment. 15 However, as both Ext1 2/216 and Ndst1/2 2/217 mouse embryos exhibit severe gastrulation defects and die early during embryonic development, these global loss-of-function models cannot be used to study vascular development and sprouting angiogenesis and the complex interplay between ECs and pericytes.
The present study examines angiogenic sprouting in differentiating stem cell cultures, so called embryoid bodies (EBs), where all ECs and pericytes exhibit defective HS biosynthesis. Elimination of HS N-sulfation was shown to result in reduced production of both HS and CS resulting in severely delayed angiogenesis, including arrest in pericyte formation. Surprisingly, the complete loss of HS production in Ext1 2/2 EBs was compatible with angiogenic sprouting and pericyte formation and resulted in increased CS biosynthesis. CS was further shown to affect TGF signaling and PDGFB signaling. Our results thus strongly suggest that many steps of the angiogenic process may be modulated by CSPGs and demonstrate a previously unrecognized functional overlap between CS and HS in the support of VEGF-induced sprouting angiogenesis.
Materials and Methods
For an expanded Materials and Methods section, please see the online-only Data Supplement.
Culture of eBs, Primary Cells, and Mouse embryonic Fibroblasts
Wild type (wt) mouse embryonic stem cells (ESCs) of the R1 strain 18 were a gift from Dr Andras Nagy (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada). The Ndst1/2 2/2 and the Ext1 2/2 ESCs were established as described 16, 19 and EBs generated according to standard procedures, 9 see the online-only Data Supplement for details. Human aortic smooth muscle cells (hAoSMCs) were purchased from Lonza and maintained in medium 231 supplemented with SMGS (Invitrogen). HUVECs (Lonza, Invitrogen) were cultured in EGM2-MV medium (Lonza, Invitrogen), and mouse embryonic fibroblasts (MEFs) cultured in high-glucose DMEM (Gibco) supplemented with 10% FBS.
Metabolic Labeling and Characterization of 35 s-labeled Glycosaminoglycans
The total glycosaminoglycan (GAG) pools containing both HS and CS produced by wt and Ext1 2/2 ESCs, or GAGs produced by EBs stimulated with VEGFA for 12 days, were metabolically labeled for 20 hours with 500 Ci of 35 S-sulfate in 10 mL of cell culture medium. The isolation of labeled GAGs is described in detail in the online-only Data Supplement. The radiolabeled GAG pools were next subjected to digestion either with 0.05 U of chondroitinase (CSase) ABC (Seikagaku) 20 to degrade CS, or treated with nitrous acid at pH 1.5 to degrade HS. The treated GAG pools were analyzed by gel chromatography on Sephadex G50 (0.53100 cm) eluted in 0.2 mol/L NaCl; fractions of 0.4 mL were collected and the 35 S-radioactivity measured.
Compositional analysis of Hs and Cs
Unlabeled HS and CS were isolated form ESCs and EBs as described in the online-only Data Supplement, and thereafter analyzed by RPIP-HPLC according to the protocols previously described by Ledin et 
immunofluorescence, Western Blotting, and signaling assays
Whole EBs in collagen gel were cut out and fixed in 4% p-formaldehyde in phosphate-buffered saline (PBS) for 30 minutes at room temperature, and thereafter blocked and permeabilized for 1 hour. The fixed EBs were incubated overnight at 4°C with primary antibodies, followed by washing and incubation with secondary antibodies the next day. Detailed procedures for analysis by immunofluorescence, Western blotting, and growth factor signaling assays are described in the online-only Data Supplement. 35 S-Labeled GAGs were purified from wt and Ext1 2/2 ESCs and EBs (stimulated with VEGFA for 12 days) and probed for binding to VEGFA-165, PDGFB, and TGF1 using the previously described nitrocellulose filter-binding assay.
Nitrocellulose Filter Binding assay

results
Ext1
2/2 eBs are Capable of sprouting angiogenesis, albeit With defective Pericyte attachment
The EB model for sprouting angiogenesis was used to study sprout formation when HS biosynthesis was eliminated or deficient in both ECs and mural cells. EBs were generated from genetically engineered mouse ESCs deficient in the HSpolymerase EXT1 or lacking the HS-modifying enzymes NDST1 and NDST2. Whereas the Ext1 2/2 ESCs have been shown to lack HS biosynthesis, Ndst1/2 2/2 ESCs synthesize an undersulfated HS containing only low levels of 6-O-sulfate groups. 19 EBs were grown in a 3-dimensional matrix of collagen I and stimulated with VEGFA165 to enhance sprouting angiogenesis.23 Both wt and Ext1 2/2 EBs showed vigorous angiogenic sprouting in response to VEGFA at day 12 of differentiation ( Figure 1A and 1D). Indeed, no significant difference in sprout area fraction was observed between wt and Ext1 2/2 EBs ( Figure 1B , 1E, and 1I), suggesting that HS is not required for early angiogenic sprouting and tube formation. However, the Ext1 2/2 EBs exhibited increased pericyte formation, accompanied by an increased occurrence of detached pericytes, as compared to the wt control ( Figure  1C , 1F, and 1J-1K). In contrast, Ndst1/2 2/2 EBs failed to produce angiogenic sprouts during the first 12 days of culture, in agreement with previous findings ( Figure 1G ), 9 whereas culture for 15 days or longer supported some formation of angiogenic sprouts in the Ndst1/2 2/2 EBs. No pericytes were however detected along the Ndst1/2 2/2 sprouts, indicating suppressed pericyte formation ( Figure 1H ).
aberrant tGFb-and PdGFB-signaling in
Ext1
2/2 eBs TGF and PDGFB have been shown to regulate pericyte differentiation and attachment. 24, 25 In agreement with the above described pericyte defects we found that both the TGF-and PDGFB-signaling pathways were affected in the Ext1 2/2 EBs. Markedly higher levels of phospho-Smad2 (a downstream target of TGF) were observed without addition of exogenous TGF in Ext1 2/2 EBs compared to the wt control, and the phospho-Smad2 levels did not increase further by acute TGF1 stimulation ( Figure 1L and 1M). We next used the in situ proximity ligation assay to determine whether PDGF-receptor beta (PDGFR) was expressed and activated in the different cultures. As shown in Figure IA in the online-only Data Supplement, PDGFR was indeed expressed and tyrosine phosphorylated in both wt and Ext1 2/2 pericytes. Next, PDGFR was immunoprecipitated to analyze the degree of tyrosine phosphorylation per receptor in response to PDGFB at different time points after stimulation. A higher degree of PDGFR phosphorylation was detected in Ext1 2/2 EBs as compared to wt EBs in all samples analyzed ( Figure 1N and1O and Figure IIA in the online-only Data Supplement). Quantitative analysis of PDGFR protein expression was performed by immunoblotting of EB lysates, and the results showed that Ext1 2/2 EBs express 50% higher levels EBs were visualized by staining for CD31 (green) and NG2 (red), respectively (C, F, G, and H). Note the absence of pericytes in Ndst1/2
2/2
EBs, and the presence of detached (star), partially detached (arrow heads) and attached (arrows) pericytes in the Ext1 2/2 EBs. The sprouting area fractions of individual EBs were quantified (I; n512) as well as the number of NG21 cells and their localization in relation to ECs (J, K; n5 11). The ability of TGF1 (5 ng/mL) to induce Smad2 phosphorylation (P-Smad2) (L, M; n53) and platelet-derived growth factor B (PDGFB) (100 ng/mL) to induce platelet-derived growth factor -receptor beta (PDGFR) phosphorylation (N) was studied in wt and Ext1
EBs. PDGFR protein was immunoprecipitated (IP) followed by immunodetection of phosphorylated tyrosine residues (P-Tyr) and PDGFR.
(O) Quantification of PDGFR phoshorylation relative to total PDGFR protein after PDGFB stimulation and IP (n52).
of PDGFR compared to wt EBs (Figure IIB in the online-only Data Supplement). Further, although not statistically significant, a tendency for decreased phosphorylation of the downstream target AKT, and increased phosphorylation of ERK1/2 was noted in the Ext1 2/2 EBs ( Figure IIC in the online-only Data Supplement). Adding either exogenous PDGFB or TGF1 to the Ext1 2/2 cultures did not rescue pericyte attachment. Instead, these growth factor treatments clearly increased both the pericyte numbers and the extent of pericyte detachment ( Figure IB in the online-only Data Supplement). Even though TGF-and PDGFB-signaling appeared dysregulated in Ext1 2/2 cultures, VEGFR2 activation was shown to be similar in VEGFA165-treated wt and Ext1 2/2 EBs (data not shown) in agreement with the strong VEGFA-induced sprouting seen in these cultures ( Figure 1D-1F ).
differentiated Cells in Ext1
2/2 eBs are incapable of Hs Biosynthesis Several aspects of angiogenesis and VEGF function have been shown to be regulated by HS. 26 The fact that Ext1
EBs formed vessels in response to VEGFA could still in theory be due to some residual HS biosynthesis during differentiation in these cultures, despite the lack of EXT1 expression. To address this issue, we isolated metabolically 35 S-labeled GAGs (including both HS and CS) from wt and Ext1 2/2 ESCs and EBs and performed GAG structural analysis.
Starting with ESCs, treatment of the total GAG pool from wt stem cells with CSase ABC, which selectively cleaves CS but not HS, resulted in degradation of approximately 50% of the material (Figure 2A ). In contrast, the total GAG pool isolated from Ext1 2/2 ESCs were completely degraded by CSase treatment, indicating that no HS was produced by the Ext1 2/2 ESCs, in full agreement with previous observations 16 ( Figure 2A ). The same experiment was repeated with labeled GAGs from differentiated EBs with vascular structures. Consistently, half of the GAG pool isolated from wt cells was degraded by CSase ( Figure 2B) . A small fraction of GAGs isolated from Ext1 2/2 EBs however appeared to be resistant to CSase treatment ( Figure 2B) . A second round of enzyme treatment nevertheless reduced the amount of intact GAGs substantially, indicating that incomplete degradation at least in part could explain the small amount of nondegraded 35 S-macromolecules in the Ext1 2/2 EB GAG preparation ( Figure 2B ). To exclude that HS was synthesized by the Ext1 2/2 EBs, the EB-derived GAG preparations were treated with nitrous acid at pH 1.5 which cleaves HS at N-sulfated residues. All GAGs isolated from Ext1
2/2
EBs resisted this treatment, whereas approximately 50% of GAGs isolated from wt EBs was degraded ( Figure 2C ). It could thus be concluded that Ext1 2/2 EBs, just like Ext1
ESCs, produce CS but not HS.
Ext1
2/2 eBs exhibit increased Cs Biosynthesis
As Ext1 2/2 EBs were unable to produce HS but still formed angiogenic sprouts, we hypothesized that CS functionally could compensate for the lack of HS. The total amounts of CS and HS synthesized by ESCs and angiogenic EBs of the different genotypes were therefore determined. Both HS and CS synthesis were increased during the course of differentiation in wt cells, although there was a decrease in the amount of both types of GAGs in Ndst1/2 2/2 EBs compared to ESCs ( Figure 3A and 3B) . Accordingly, Ndst1/2 2/2 EBs may be regarded as null mutants for both HS and CS biosynthesis, providing an explanation for the markedly delayed formation of sprouts in these cultures ( Figure 1G and 1H) . The levels of HS produced by the Ext1 2/2 ESCs or EBs were at the limit of detection ( Figure 3A ) and therefore considered to be insignificant background signals, in agreement with the data presented in Figure 2 . Notably, the total amounts of CS recovered were twice as high in Ext1 2/2 ESCs and EBs as compared to wt cells ( Figure 3B ). The detailed sulfation patterns of wt and Ext1 2/ 2-derived CS revealed that in both cases the majority of CS disaccharide units were 4-O-sulfated. Also, there was no substantial difference between wt and Ext1 2/2 cells with regard to overall degree or pattern of sulfation of CS, as determined by disaccharide analysis ( Figure 3C and Figure III in the online-only Data Supplement). Taken together, analysis of HS and CS produced by wt , and Ext1 2/2 ES cells (B). The overall sulfate content of CS (C), specified according to type of substituent as total 2-O-sulfated (2S), total 6-O-sulfated (6S), and total 4-O-sulfated disaccharides (4S), demonstrate increased production of CS in Ext1 2/2 cultures, albeit with normal degree of sulfation. The expression levels of core proteins and enzymes involved in CS biosynthesis were initially analyzed in ECs as well as in non-ECs isolated from both Ext1 2/2 and wt EBs using a qPCR screen ( Figure IV and Table I in the online-only Data Supplement, and data not shown). Validation of the expression of selected genes was thereafter performed by additional qPCR analyses (Figure 3D-3F) . Endocan, known to carry CS, was found to be equally expressed in CD31-positive ECs isolated from VEGFA-induced wt and Ext1 2/2 EBs, whereas no endocan mRNA was detected in the non-EC fraction (CD31-negative) ( Figure 3D ). In contrast, the expression levels of the CS-bearing proteoglycan core proteins decorin and NG2 were increased more than 5-and 10-fold, respectively, in non-ECs isolated from Ext1 2/2 EBs as compared to wt ( Figure 3E and 3F). Other genes linked to CS biosynthesis were expressed at equal levels in Ext1 2/2 and wt cultures (data not shown). These results demonstrate that the increased production of CS in Ext1 2/2 cultures is accompanied by increased expression of proteoglycan core proteins. Figure 4E and 4F) ; degradation of HS was without significant effects. Admittedly, the here performed enzymatic degradation of extracellular HS and CS, although efficient, is likely incomplete, providing an explanation for the small effects recorded on VEGFA-and PDGFB-signaling in HUVECs and hAoSMCs, respectively. We therefore turned to the Ndst1 2/2 mouse embryonic fibroblast (MEF) model. Abramsson and coworkers have previously shown that PDGFB signaling in these cells, expressing normal levels of CS, is reduced due to reduced levels of functional HS. 9 Using the Ndst1 2/2 MEF model, we could show that PDGFB signaling could be further reduced by degradation of CS by CSase treatment ( Figure 4G and Figure VIB in the online-only Data Supplement), providing additional evidence for the involvement of CS in angiogenic growth factor signaling.
Cs interacts With and supports PdGFB-and tGFb-signaling
discussion
The present study demonstrates for the first time that angiogenic sprouting can occur in the absence of HS biosynthesis. Ext1 2/2 EBs, unable to synthesize HS but exhibiting increased CS biosynthesis, were accordingly shown to form vascular sprouts in response to VEGFA. The main morphological phenotypes detected in the Ext1 2/2 condition were increased formation of pericytes, accompanied by an increased extent of pericyte detachment from the vessel sprouts. Sprout formation in Ndst1/2 2/2 EBs was, on the other hand, severely compromised, and pericytes did not form in these cultures. This result is in agreement with the finding that differentiated Ndst1/2
2/2
EBs are effective "double knockouts" for both HS and CS ( Figure 3) . Thus, although sprout formation indeed is dependent on GAG function, our data suggest that selective loss of HS production in part can be compensated by increased CS biosynthesis. The fact that the CS-producing Ext1 2/2 EBs but not the GAG-null Ndst1/2 2/2 EBs supported angiogenesis strongly argue for a functional overlap between HS and CS in sprouting angiogenesis ( Figure 5 ). Importantly, these results challenge the view that HS is strictly required for all steps of the angiogenic process, and strengthen the notion that there is a broad selectivity for interactions between protein ligands and equally sulfated, yet distinct, HS and CS epitopes. 12 It is outside the scope of this study to identify the mechanism behind the increased CS biosynthesis in Ext1 2/2 EBs. However, HS and CS biosynthesis share some common substrates (uridine diphosphate-sugars and the sulfate donor 3-phosphoadenisine-5-phosphosulfate), and utilize the same tetrasaccharide linkage region for initiation of biosynthesis onto core proteins. A reduction in HS biosynthesis will thus likely result in more available substrates for CS biosynthesis, providing an explanation to the increased production of CS in Ext1 2/2 EBs. The defect in pericyte attachment found in Ext1 2/2 EBs was mirrored at the level of TGF signaling and PDGFR phosphorylation. A trend was also seen for altered activation of AKT and ERK1/2 in response to PDGFB in Ext1 2/2 EBs. Dysregulated TGF and PDGFB signaling (Figure 1 ) offer highly plausible mechanisms for the observed loss in pericyte attachment in Ext1 2/2 EBs. TGF signaling has previously been shown to promote pericyte differentiation,24 and the increased TGF signaling may therefore explain the higher pericyte number in the Ext1 2/2 EBs. The Ext1 2/2 phenotype was not rescued by the addition of exogenous PDGFB or TGF1. Instead, both the number of pericytes and the extent of detachment were further increased by the exogenous addition of these growth factors ( Figure IB in the online-only Data Supplement), emphasizing the need for regulated presentation of these factors, likely in the form of properly shaped and maintained extracellular concentration gradients.
The CS produced by the Ext1 2/2 EBs was capable of binding TGF, PDGFB, and VEGFA. Notably, the expression levels of CS biosynthetic enzymes were unchanged in these cultures, although the amounts of some of the CS-modified core proteins, eg, decorin and NG2 were increased, which may be linked to the increased production of CS. Decorin belongs to the family of small leucine rich proteoglycans and has been shown to regulate extracellular matrix organization as well as growth factor signaling. [27] [28] [29] [30] Indeed, decorin binds to PDGFB and may inhibit PDGFB-stimulated vascular smooth muscle cell function in a dose-dependent manner. 28 Interestingly, the active form of TGF known to mediate the de novo induction of pericytes from the mesenchymal cell lineage during embryonic development also binds to decorin in the extracellular matrix. 31 In addition, decorin has been shown to inhibit or stimulate angiogenesis dependent on the biological context. [32] [33] [34] [35] NG2 has also been shown to play a role in pathological angiogenesis via interactions with antiangiogenic factors as well as with FGF2 and different PDGFs. [36] [37] [38] Our data furthermore suggest that CS is required for proper TGF signaling. The mechanisms underlying the sensitivity to loss of CS displayed in our analyses of TGF signaling is unclear (Figure 4) . However, the fact that CSase treatment reduced TGF/TGFR signaling in hAoSMCS suggests that CS could be engaged in ternary complexes together with growth factors and receptors to promote receptor complex assembly. 39, 40 Interestingly, TGF receptor III or betaglycan is a "promiscuous" proteoglycan that has the capacity to carry either HS chains or CS chains, both HS and CS at the same time, or no GAG chains at all. 41 The betaglycan protein core has further been shown to bind TGF and to act as a TGF coreceptor by facilitating TGF receptor I/ TGF receptor III complex formation. 42, 43 The chemical nature of the GAG influences TGF receptor III activity,44 but the exact role of the different GAGs in TGF receptor III function is still not well understood. We suggest that disturbed balance between HS and CS production (as seen in Ext1 2/2 EBs) impacts the GAG composition of TGF receptor III and consequently alters signaling. Finally, using the Ndst1 2/2 MEF model, we could show that PDGFB signaling in a genetic background where HS biosynthesis but not CS biosynthesis is suppressed could be further reduced by CSase treatment (Figure 4G ), providing evidence for a modulatory role of CS in PDGFB signal transduction.
Pathological conditions characterized by vessel immaturity, vessel excess, or dysregulated growth factor production, are often accompanied by pericyte detachment. Pericyte detachment or other types of pericyte deficiencies have been shown to lead to increased vessel tortuosity and leakage, as well as to the formation of microaneurysms, with an increased risk for bleedings. Interestingly, metastatic spread of cancer may be facilitated by vessel instability at least in part due to the lack of attached pericytes. 45, 46 Here, EXT1-deficiency and decreased HS production was accompanied by pericyte detachment from angiogenic sprouts. PDGFR signaling was decreased in the Ext1 2/2 EBs, which expressed increased levels of CS. We suggest that CS-dependent elevation of TGF signaling (Figure 1 ) may indirectly affect the cellular response to PDGFB.
It is tempting to speculate that the observed functional overlap between HS and CS may be relevant not only to angiogenic sprouting, but also to other complex morphogenetic processes influenced by GAG-binding growth factors. Tampering with HS biosynthesis could represent a possible way to target HS-protein interactions of pathophysiological significance. Efforts are indeed ongoing to evaluate GAG-mimetics or inhibition of HS biosynthesis for therapeutic purposes. 47 However, the partial functional overlap between HSPGs and CSPGs demonstrated by the present study suggests that targeting of either HS or CS production alone may not be sufficient to efficiently inhibit angiogenesis. Further, inhibition of HS depending on strategy may also affect CS biosynthesis, as seen here with the 2-fold increase in CS biosyntheis in Ext1 2/2 EBs. Finally, simultaneous blocking of both HS and CS biosynthesis would probably also lead to severe side effects. At any rate, the close link between HS and CS biosynthesis, as well as their overlapping functions, should be kept in mind when considering future drug strategies to influence GAG-modulated biological processes.
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